Communicable Diseases & Immunisation Conference 2026
'Public Health at Risk - Collective Solutions to New Challenges'
Monday 15 to Wednesday 17 June 2026 | Marvel Stadium Melbourne/Naarm, Wurundjeri Country, VIC
#CDIC2026
Sponsors & Exhibitors
We would like to thank the following sponsors and exhibitors for their support of the Communicable Diseases & Immunisation Conference 2026.
Associate Sponsor and Exhibitor - Feery Oration Sponsor
CSL Seqirus
A: 655 Elizabeth Street, Melbourne, VIC 3000
T: 0434 608 564
E: Leonie.Loyer@Seqirus.com
W: https://www.cslseqirus.com.au/
As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to public health through the prevention of influenza and pandemic preparedness. With state-of-the-art production facilities and leading R&D capabilities, CSL Seqirus utilizes egg, cell and adjuvant technologies to offer a broad portfolio of differentiated influenza vaccines in more than 20 countries around the world.
In Australia, CSL Seqirus operates the only manufacturing facility for seasonal and pandemic influenza vaccines, and produces a range of unique medicines in the national interest including antivenoms and the only human vaccine for Q fever. Our commitment to Australia’s health also extends to providing access to paediatric and adult vaccines, and innovative pharmaceuticals for patients living with allergies, cardiovascular disease, severe pain, dry eye disease, iron deficiency, kidney diseases, rare diseases and neurological conditions.
Associate Sponsor and Exhibitor - GSK Awards
GSK Australia
A: Level 4, 436 Johnston Street, Abbotsford, VIC 8003
T: +61 457 189 109
E: Lauren.j.anelay@gsk.com
GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease. At the heart of this is our R&D focus on the science of the immune system, human genetics and advanced technologies, and our world-leading capabilities in vaccines and medicines development. We focus on four therapeutic areas: infectious diseases, HIV, oncology, and immunology.
Associate Sponsor and Exhibitor
MSD
A: 26 Talavera Road, Macquarie Park, NSW 2113
T: 0437 758 151
E: daniel.barnaby@msd.com
W:https://www.msd-australia.com.au/
At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd-australia.com.au.
Associate Sponsor and Exhibitor - Pfizer Scholarship Sponsor
Pfizer Australia Pty Ltd
Media Relations, Pfizer Australia Pty Ltd
A: Lvl 17, 151 Clarence Street, Sydney NSW 2000
P: +61 2 9850 3333
About Pfizer Australia: Breakthroughs that change patients’ lives™
At Pfizer, we apply science and our global resources to improve health and wellbeing at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of innovative medicines, with a diversified global healthcare portfolio, including biologic and small molecule medicines and vaccines.
Consistent with our responsibility as the world's leading biopharmaceutical company, we also collaborate with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare. For more information, visit: www.pfizer.com.au.
Associate Sponsor and Exhibitor
Sanofi
A: Level 23, Tower 3, International Towers, 300 Barangaroo Avenue, Sydney NSW, 2000
T: +61 412730027
W: Sanofi Australia & New Zealand: global healthcare and pharmaceutical company
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people's lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the centre of our ambitions.
Support Sponsor and Exhibitor
Astra Zeneca
A: 66 Talavera Road, Macquarie Park, NSW 2113
T: 0422 994 429
E: byron.nyin@astrazeneca.com
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines and vaccines, primarily for diseases in four therapy areas – Oncology; Cardiovascular, Renal and Metabolism (CVRM); Respiratory and Immunology (R&I); and Rare Disease. We build our own capabilities by collaborating with world-renowned scientists and academic institutions, and partner with like-minded, science-led companies. At AstraZeneca Australia, we have been working to deliver the best value to patients for more than 60 years, and we push the boundaries of science to deliver life-changing medicines and vaccines.
Welcome Reception Sponsor
Moderna
A: L49, 101 Collins Street, Melbourne VIC 3000
E: Belinda.anderson@modernatx.co
Moderna is biotechnology company focused on the development of mRNA medicines. Through the advancement of its mRNA technology platform, Moderna is exploring new approaches to how medicines are made, with the aim of improving prevention and treatment of diseases. Since its founding, Moderna's mRNA platform has supported the research and development of vaccines and therapeutics across infectious diseases, cancer and rare diseases.
With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines.
For more information about Moderna,please visit modernatx.com.au
Exhibitor
National Centre for Immunisation Research and Surveillance (NCIRS)
NCIRS
A: Corner Hawkesbury Road and Hainsworth Street, Westmead NSW 2145
E: SCHN-NCIRS@health.nsw.gov.au
The National Centre for Immunisation Research and Surveillance (NCIRS) is Australia’s leading organisation in immunisation and vaccines. NCIRS provides expert advice to support evidence-informed immunisation policy and guideline development; evaluation of immunisation programs, particularly the National Immunisation Program; and the monitoring of vaccine-preventable diseases, vaccine coverage, and factors impacting vaccine uptake and vaccine safety. The organisation is nationally and internationally recognised in these arenas and has a growing program of global health work focused on the provision of technical support for immunisation system strengthening to countries in Asia and the Pacific.
Exhibitor
Survey Design and Analysis Services
.png)
A: Unit 801, 241 Northbourne Avenue, Lyneham, ACT 2602
T: 02 6247 0177
E: David.white@surveydesign.com.au
Stata is a complete statistical and data science platform for managing, analysing, and visualising data with precision and reproducibility. From regression and modelling to survey analysis and reporting, Stata delivers trusted results.
Survey Design & Analysis Services (SDAS) – Australia’s trusted Stata distributor.
Abstract Awards Sponsor
University of Tasmania
Further information to follow soon.
Host
Public Health Association of Australia (PHAA)
A: PO Box 319, Curtin, ACT, 2605
T: 02 6285 2373
E: events@phaa.net.au
The Public Health Association of Australia (PHAA) is recognised as the principal non-government organisation for public health in Australia and works to promote the health and well-being of all Australians. The Association seeks better population health outcomes based on prevention, the social determinants of health and equity principles. PHAA is a national organisation comprising around 1900 individual members and representing over 40 professional groups concerned with the promotion of health at a population level. Via our conferences, workshops, forums and other member events, we bring together those seeking to debate scientific evidence, policy and program evaluation and options for the further and better development of public health in Australia.